Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake

Key Takeaways Insmed posted a Q3 loss of $1.75 per share, missing estimates despite higher revenue.Brinsupri added $28.1M in its first quarter of sales, driving strong investor optimism.Revenue rose 52% to $142.3M on growth in Arikayce and the successful Brinsupri launch.Insmed (INSM) reported a third-quarter 2025 loss of $1.75 per share, which was wider than the Zacks Consensus Estimate of a loss of $1.32. In the year-ago quarter, the company posted a loss of $1.27 per share.Quarterly revenues rose 52% yea ...